搜尋結果
Oh, Canada: U.S. Patients Don't Want Your Health Policies
Forbes· 11 小時前There's never been a worse time to get sick in Canada. The Canadian government has ... ...
Billionaire Agnellis Bought US Legal Risk and Won
Bloomberg· 4 小時前The family took a stake in medical devices firm Philips when the
US FDA approves X4 Pharmaceuticals' therapy for immunodeficiency disease
Reuters· 4 小時前, opens new tab said on Monday the U.S. FDA has approved its therapy to treat < ...
Walgreens’ Next Frontier: Complex Conditions & Cell And Gene Therapy
Forbes· 11 小時前With the launch of this new initiative, Walgreens aims to focus on a</ ...
Abeona shares tumble as FDA declines to approve skin disorder treatment
Reuters· 7 日前, opens new tab said on Monday the U.S. Food and Drug Administration ...
Here are 5 sectors of the market that are working and the stocks that stand out in each ...
CNBC· 19 小時前Can it be put in a data center? Let's dispense with the macro before I get into what's ...
White House Plan To Curb Drug Shortages Doesn’t Address Generics’ Quality
Forbes· 5 日前Drug shortages are at an all-time high. The White House rolled out a</ ...
HSBC wealth investor is convinced four secular themes will keep the U.S. economy humming along ...
CNBC· 1 日前"From a business cycle dynamics perspective, the Fed raised rates, nothing happened ... ...
Higher Medical Costs Likely Weighed On CVS Health’s Q1 Earnings
Forbes· 11 小時前Earnings will likely come in at about $1.74 on a per-share and adjusted basis, slightly ... ...
What Social Media May Not Tell You About Weight-Loss Drugs - Tech News Briefing - WSJ Podcasts
The Wall Street Journal· 3 日前Coming up on today's show, a hack into healthcare technology company Change Healthcare ... ...